Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia.
Martinelli S, Maffei R, Fiorcari S, Quadrelli C, Zucchini P, Benatti S, Potenza L, Luppi M, Marasca R.
Martinelli S, et al. Among authors: luppi m.
Haematologica. 2018 Dec;103(12):e598-e601. doi: 10.3324/haematol.2017.187070. Epub 2018 Jul 5.
Haematologica. 2018.
PMID: 29976737
Free PMC article.
No abstract available.